These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 28797063

  • 1. CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis.
    Chee CG, Kim YH, Lee KH, Lee YJ, Park JH, Lee HS, Ahn S, Kim B.
    PLoS One; 2017; 12(8):e0182883. PubMed ID: 28797063
    [Abstract] [Full Text] [Related]

  • 2. Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy.
    Jalil O, Afaq A, Ganeshan B, Patel UB, Boone D, Endozo R, Groves A, Sizer B, Arulampalam T.
    Colorectal Dis; 2017 Apr; 19(4):349-362. PubMed ID: 27538267
    [Abstract] [Full Text] [Related]

  • 3. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
    Bang JI, Ha S, Kang SB, Lee KW, Lee HS, Kim JS, Oh HK, Lee HY, Kim SE.
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):422-31. PubMed ID: 26338180
    [Abstract] [Full Text] [Related]

  • 4. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival.
    Ng F, Ganeshan B, Kozarski R, Miles KA, Goh V.
    Radiology; 2013 Jan; 266(1):177-84. PubMed ID: 23151829
    [Abstract] [Full Text] [Related]

  • 5. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
    Shu Z, Fang S, Ding Z, Mao D, Pang P, Gong X.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep 25; 21(9):1051-1058. PubMed ID: 30269327
    [Abstract] [Full Text] [Related]

  • 6. Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance.
    De Cecco CN, Ganeshan B, Ciolina M, Rengo M, Meinel FG, Musio D, De Felice F, Raffetto N, Tombolini V, Laghi A.
    Invest Radiol; 2015 Apr 25; 50(4):239-45. PubMed ID: 25501017
    [Abstract] [Full Text] [Related]

  • 7. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Reggiani Bonetti L, Lionti S, Domati F, Pagliani G, Mattioli E, Barresi V.
    Histopathology; 2017 Sep 25; 71(3):393-405. PubMed ID: 28425130
    [Abstract] [Full Text] [Related]

  • 8. Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
    Aker M, Ganeshan B, Afaq A, Wan S, Groves AM, Arulampalam T.
    Dis Colon Rectum; 2019 Feb 25; 62(2):163-170. PubMed ID: 30451764
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of the texture analysis parameters of the initial computed tomographic scan for response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.
    Vandendorpe B, Durot C, Lebellec L, Le Deley MC, Sylla D, Bimbai AM, Amroun K, Ramiandrisoa F, Cordoba A, Mirabel X, Hoeffel C, Pasquier D, Servagi-Vernat S.
    Radiother Oncol; 2019 Jun 25; 135():153-160. PubMed ID: 31015162
    [Abstract] [Full Text] [Related]

  • 10. MRI features and texture analysis for the early prediction of therapeutic response to neoadjuvant chemoradiotherapy and tumor recurrence of locally advanced rectal cancer.
    Park H, Kim KA, Jung JH, Rhie J, Choi SY.
    Eur Radiol; 2020 Aug 25; 30(8):4201-4211. PubMed ID: 32270317
    [Abstract] [Full Text] [Related]

  • 11. Modified 3-Point MRI-Based Tumor Regression Grade Incorporating DWI for Locally Advanced Rectal Cancer.
    Lee MA, Cho SH, Seo AN, Kim HJ, Shin KM, Kim SH, Choi GS.
    AJR Am J Roentgenol; 2017 Dec 25; 209(6):1247-1255. PubMed ID: 28981353
    [Abstract] [Full Text] [Related]

  • 12. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S, Arrangoiz R, Nitzkorski JR, Yu JQ, Li T, Cooper H, Konski A, Farma JM, Sigurdson ER.
    Ann Surg Oncol; 2012 Jul 25; 19(7):2178-85. PubMed ID: 22395978
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy.
    Wen B, Zhang L, Wang C, Huang R, Peng H, Zhang T, Dong J, Xiao W, Zeng Z, Liu M, Gao Y.
    Radiat Oncol; 2015 Jun 04; 10():124. PubMed ID: 26040453
    [Abstract] [Full Text] [Related]

  • 14. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B, Obuz F, Elibol FD, Celik AO, Sokmen S, Terzi C, Sagol O, Sarioglu S, Gorken I, Oztop I.
    Magn Reson Imaging; 2015 Feb 04; 33(2):201-12. PubMed ID: 25460330
    [Abstract] [Full Text] [Related]

  • 15. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer.
    Yoon HJ, Kim SK, Kim TS, Im HJ, Lee ES, Kim HC, Park JW, Chang HJ, Choi HS, Kim DY, Oh JH.
    Clin Nucl Med; 2013 Jan 04; 38(1):7-12. PubMed ID: 23242038
    [Abstract] [Full Text] [Related]

  • 16. Hepatocellular Carcinoma: Texture Analysis of Preoperative Computed Tomography Images Can Provide Markers of Tumor Grade and Disease-Free Survival.
    Oh J, Lee JM, Park J, Joo I, Yoon JH, Lee DH, Ganeshan B, Han JK.
    Korean J Radiol; 2019 Apr 04; 20(4):569-579. PubMed ID: 30887739
    [Abstract] [Full Text] [Related]

  • 17. Tumor radiomic features complement clinico-radiological factors in predicting long-term local control and laryngectomy free survival in locally advanced laryngo-pharyngeal cancers.
    Agarwal JP, Sinha S, Goda JS, Joshi K, Mhatre R, Kannan S, Laskar SG, Gupta T, Murthy V, Budrukkar A, Mummudi N, Ganeshan B.
    Br J Radiol; 2020 May 01; 93(1109):20190857. PubMed ID: 32101463
    [Abstract] [Full Text] [Related]

  • 18. Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
    Zhang LN, Xiao WW, Xi SY, OuYang PY, You KY, Zeng ZF, Ding PR, Zhang HZ, Pan ZZ, Xu RH, Gao YH.
    Oncotarget; 2016 Feb 02; 7(5):6335-44. PubMed ID: 26695441
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Computed tomography-derived biomarker for predicting the treatment response to neoadjuvant chemoradiotherapy of rectal cancer.
    Kurata Y, Hayano K, Ohira G, Imanishi S, Tochigi T, Isozaki T, Aoyagi T, Matsubara H.
    Int J Clin Oncol; 2021 Dec 02; 26(12):2246-2254. PubMed ID: 34585288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.